Vir Biotechnology (VIR) Revenue (2018 - 2025)
Historic Revenue for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to $240000.0.
- Vir Biotechnology's Revenue fell 8991.6% to $240000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $16.9 million, marking a year-over-year decrease of 7855.45%. This contributed to the annual value of $74.2 million for FY2024, which is 1389.53% down from last year.
- Latest data reveals that Vir Biotechnology reported Revenue of $240000.0 as of Q3 2025, which was down 8991.6% from $1.2 million recorded in Q2 2025.
- In the past 5 years, Vir Biotechnology's Revenue ranged from a high of $1.2 billion in Q1 2022 and a low of $240000.0 during Q3 2025
- Over the past 5 years, Vir Biotechnology's median Revenue value was $16.8 million (recorded in 2023), while the average stood at $155.2 million.
- As far as peak fluctuations go, Vir Biotechnology's Revenue surged by 6227140.69% in 2022, and later tumbled by 9929.54% in 2023.
- Over the past 5 years, Vir Biotechnology's Revenue (Quarter) stood at $812.7 million in 2021, then crashed by 93.92% to $49.4 million in 2022, then crashed by 66.03% to $16.8 million in 2023, then fell by 26.29% to $12.4 million in 2024, then plummeted by 98.06% to $240000.0 in 2025.
- Its Revenue was $240000.0 in Q3 2025, compared to $1.2 million in Q2 2025 and $3.0 million in Q1 2025.